Alaunos TherapeuticsTCRT
13F holders, Q2 2025 (June 30)28holders −1
3new positions
4sold out
$4.85avg. 13F price*
At the end of Q2 2025, 28 institutions reported holding Alaunos Therapeutics Inc. (TCRT) in their 13F filings, down 1 from Q1 2025. 3 opened new positions and 4 sold out. The largest holders were BlackRock, Inc. ($104K), Vanguard Group Inc. ($102K) and Geode Capital Management, LLC ($77K).
- Company
- Alaunos Therapeutics Inc.
- CUSIP
- 98973P309
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $611 |
| Exits | 4 | $27 |
All 13F filers, Q1 2025 → Q2 2025: 2,363 shares bought and 2,016 shares sold, net +347 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 28 holders
| BlackRock, Inc. | 0.00% | No change | 21,353 | $104K |
| Vanguard Group Inc. | 0.00% | No change | 20,972 | $102K |
| Geode Capital Management, LLC | 0.00% | Add +2.1% | 15,946 | $77K |
| UBS Group AG | 0.00% | Reduce -13.4% | 6,815 | $33K |
| Morgan Stanley | 0.00% | Add +100.5% | 1,798 | $9K |
| Steward Partners Investment Advisory, LLC | 0.00% | Add +1020.4% | 1,098 | $5K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -42.0% | 973 | $5K |
| Osaic Holdings, Inc. | 0.00% | Reduce -3.5% | 695 | $3K |
| Group One Trading LLC | 0.00% | No change | 300 | $1K |
| CIBC Private Wealth Group LLC | 0.00% | No change | 300 | $1K |
| Wells Fargo & Company | 0.00% | Reduce -15.3% | 183 | $888 |
| Barclays PLC | 0.00% | Reduce -41.5% | 100 | $485 |
| Raymond James Financial Inc. | 0.00% | New | 99 | $480 |
| Federation des caisses Desjardins du Quebec | 0.00% | No change | 86 | $417 |
| Bank of America Corp. | 0.00% | Reduce -4.5% | 85 | $412 |
| Bokf, NA | 0.00% | No change | 66 | $320 |
| Asset Dedication, LLC | 0.00% | Reduce -14.8% | 46 | $224 |
| Key Financial Inc | 0.00% | New | 24 | $116 |
| NFSG Corp | 0.00% | No change | 24 | $116 |
| Signaturefd, LLC | 0.00% | No change | 23 | $112 |
| Thurston, Springer, Miller, Herd & Titak, Inc. | 0.00% | No change | 21 | $101 |
| AdvisorNet Financial, Inc | 0.00% | No change | 19 | $92 |
| Investment Management Corp. /Va/ | 0.00% | No change | 6 | $29 |
| BNP Paribas Financial Markets | 0.00% | No change | 6 | $29 |
| Sunbelt Securities, Inc. | 0.00% | No change | 10 | $19 |
| JPMorgan Chase & Co. | 0.00% | New | 3 | $15 |
| Truvestments Capital LLC | 0.00% | No change | 1 | $5 |
| Cwm, LLC | 0.00% | No change | 8 | $0 |
"% of holder's portfolio" is TCRT's weight in each manager's 13F, not the share of Alaunos Therapeutics Inc. the manager owns.